In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...
Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva's generic copy ...
The breakthrough in drug delivery hinges on the development of nanoarchaeosomes, which are nanoparticles loaded with ...
This post is part of MoFo’s 2025 Intersection of AI and Life Sciences blog series. In this blog series, we explore how ...
AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...
With the settlement, Teva will not market the Auvelity generic until September 30, 2038, Axsome said in a Monday press ...
Researchers at the Indian Institute of Technology (IIT), Madras have developed and patented a nextgGeneration drug delivery system to treat breast cancer, which is one of the leading causes of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results